Injectable Drug Delivery: Probing the Route to Growth

Introduction

The injectable drug delivery market is growing. Rising 16.3% to an estimated $83 billion in 2002, it is forecast to grow at a CAGR of 10% between 2002 and 2008. The increasing use of reformulation techniques earlier in product lifecycles is changing the dynamics of the injectables field, and players will need to evolve if they are to capitalize on the opportunities offered by the growing market 

Scope

Analysis of the injectables portfolio and pipeline for the top 40 pharmaceutical companies 

Benchmarking of the current and future injectables market by technology and therapeutic focus 

Full profiles of 6 leading injectable drug delivery players, encompassing company strategy, alliance network, and portfolio and pipeline analysis 

Analysis of product sourcing and marketing strategies of 37 injectable drug delivery players 

Report Highlights

Use of injectable drug delivery to optimize administration of the growing number of protein-based products and, as an effective lifecycle management tool in the increasingly competitive pharmaceutical market, is expected to drive strong growth of the injectables market over the next five years 

Within the injectables market companies can position themselves as injectable specialists or multi-platform players, and can operate along the scale from technology service provider to fully integrated player. Specialists are well suited for a service provider strategy, while multi-platform players will benefit from moving toward full integration 

Competition within the injectable drug delivery market is increasing as non-invasive methods of drug administration begin to encroach on traditionally injectable market areas. Injectable players must continue to develop or acquire new drug delivery technologies to maintain a competitive advantage 

Reasons to Purchase

Benchmark your position within the injectable drug delivery market and identify the optimum strategy for future growth 

Understand trends across technological and therapeutic fields to target resources effectively and recognize pipeline opportunities 

Optimize your market penetration through comprehensive knowledge of the growth drivers and corporate dynamics of the injectable market. 

Published: January 2004 Pages: 176 

Publisher: Datamonitor Drug Delivery Reports 

To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/Datamonitor_Drug_delivery.html#a557